Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Domperidone maleate
Noumed Life Sciences Ltd
A03FA03
Domperidone maleate
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04060000; GTIN: 05060453465028 05060453460115
2 1 LDOM00/02 280mm 275mm PACKAGE LEAFLET: INFORMATION FOR THE USER Domperidone 10mg Tablets (domperidone maleate) This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects. Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Domperidone Tablets are and what they are used for 2. What you need to know before you take Domperidone Tablets 3. How to take Domperidone Tablets 4. Possible side effects 5. How to store Domperidone Tablets 6. Contents of the pack and other information 1. WHAT DOMPERIDONE TABLETS ARE AND WHAT THEY ARE USED FOR Domperidone Tablets contain domperidone as the active ingredient, which belongs to a group of medicines called 'dopamine antagonists'. Domperidone works by helping to move food faster through your food pipe (oesophagus), stomach and gut. This is so that it does not stay in the same place for too long. It also helps stop food flowing the wrong way back up your food pipe. This medicine is used to treat nausea (feeling sick) and vomiting (being sick) in adults and adolescents (12 years of age and older and weighing 35 kg or more). You must talk to a doctor if you do not feel better or if you feel worse. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DOMPERIDONE TABLETS Do not take Domperidone Tablets if you: • are allergic (hypersensitive) to domperidone or any of the other ingredients of this medicine (listed Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS ▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See the end of section 4.8 for how to report side effects. 1 NAME OF THE MEDICINAL PRODUCT Domperidone 10mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITIONS: Each tablet contains Domperidone maleate equivalent to 10mg domperidone base. Excipient(s) with known effect Each tablet contains 54.20mg of lactose monohydrate For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablets White round biconvex tablet with “Dm 10” inscription on one side. 4.1 THERAPEUTIC INDICATIONS: Domperidone is indicated in adults and adolescents 12 years of age and older with a body weight of 35kg or more for the relief of the symptoms of nausea and vomiting. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION: Posology Domperidone should be used at the lowest effective dose for the shortest duration necessary to control nausea and vomiting. It is recommended to take oral domperidone before meals. If taken after meals, absorption of the drug is somewhat delayed. Patients should try to take each dose at the scheduled time. If a scheduled dose is missed, the missed dose should be omitted and the usual dosing schedule resumed. The dose should not be doubled to make up for a missed dose. Usually, the maximum treatment duration should not exceed one week (See section 4.4). _Adults and adolescents (over12 years and weighing 35kg or more): _ _ _ One 10 mg tablet up to three times per day with a maximum dose of 30 mg per day. Hepatic Impairment Domperidone is contraindicated in moderate or severe hepatic impairment (see section 4.3). Dose modification in mild hepatic impairment is however not needed (see section 5.2). Renal Impairment Since the elimination half-life of domperidone is prolonged in severe renal impairment, on repeated administration, the dosing frequency of domperidone should be r Read the complete document